Oric Pharmaceuticals (ORIC) Cash from Operations (2019 - 2026)
Oric Pharmaceuticals filings provide 8 years of Cash from Operations readings, the most recent being 32438000.0 for Q1 2026.
- Quarterly Cash from Operations changed 0.29% to 32438000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 110875000.0 through Mar 2026, up 3.59% year-over-year, with the annual reading at 110970000.0 for FY2025, 1.5% up from the prior year.
- Cash from Operations hit 32438000.0 in Q1 2026 for Oric Pharmaceuticals, down from 22483000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 15329000.0 in Q4 2022 and bottomed at 32533000.0 in Q1 2025.
- Average Cash from Operations over 5 years is 24523588.24, with a median of 24270000.0 recorded in 2023.
- The largest annual shift saw Cash from Operations plummeted 59.12% in 2022 before it increased 19.86% in 2025.
- Oric Pharmaceuticals' Cash from Operations stood at 15329000.0 in 2022, then plummeted by 58.33% to 24270000.0 in 2023, then dropped by 15.59% to 28054000.0 in 2024, then grew by 19.86% to 22483000.0 in 2025, then crashed by 44.28% to 32438000.0 in 2026.
- Per Business Quant, the three most recent readings for ORIC's Cash from Operations are 32438000.0 (Q1 2026), 22483000.0 (Q4 2025), and 25112000.0 (Q3 2025).